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ABSTRACT Gangliosides are glycosphingolipids highly enriched in neural plasma
membranes, where they mediate a diverse range of functions and can act as targets
for auto-antibodies present in human immune-mediated neuropathy sera. The ensuing
autoimmune injury results in axonal and motor nerve terminal (mNT) degeneration.
Both aging and ganglioside-deficiency have been linked to impaired axonal regenera-
tion. To assess the effects of age and ganglioside expression on mNT regeneration in
an autoimmune injury paradigm, anti-ganglioside antibodies and complement were
applied to young adult and aged mice wildtype (WT) mice, mice deficient in either b-
and c-series (GD3sKO) or mice deficient in all complex gangliosides (GM2sKO). The
extent of mNT injury and regeneration was assessed immediately or after 5 days,
respectively. Depending on ganglioside expression and antibody-specificity, either a
selective mNT injury or a combined injury of mNTs and neuromuscular glial cells was
elicited. Immediately after induction of the injury, between 1.5% and 11.8% of neuro-
muscular junctions (NMJs) in the young adult groups exhibited healthy mNTs. Five
days later, most NMJs, regardless of age and strain, had recovered their mNTs. No sig-
nificant differences could be observed between young and aged WT and GM2sKO mice;
aged GD3sKO showed a mildly impaired rate of mNT regeneration when compared
with their younger counterparts. Comparable rates were observed between all strains
in the young and the aged mice. In summary, the rate of mNT regeneration following
anti-ganglioside antibody and complement-mediated injury does not differ majorly
between young adult and aged mice irrespective of the expression of particular gan-
gliosides. Synapse 67:382–389, 2013. VC 2013 Wiley Periodicals, Inc.
INTRODUCTION
Gangliosides are glycosphingolipids found within
microdomains on cell membranes throughout the
body, but enriched in neural tissue (Hamberger and
Svennerholm, 1971; Yu et al., 2011). Different gan-
gliosides are distinguished from one another by the
number and location of sialic acid residues attached
to a neutral sugar backbone ((Svennerholm, 1963; Yu
et al., 2011); Fig. 1). The function of gangliosides is
very diverse, ranging from neural development, axo-
nal growth, signal transduction, modulation of mem-
brane proteins, node of Ranvier stability and receptor
functions, to cell–cell interactions (Plomp and Willi-
son, 2009; Susuki et al., 2007; Zeller and Marchase,
1992). In disease-related roles, they act as targets for
toxins and autoantibodies (autoAbs).
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Anti-ganglioside antibodies (Abs) are observed in
patients suffering from the human peripheral nerve
disorder Guillain-Barre syndrome (GBS) (Yuki and
Hartung, 2012) and are believed to be pathogenic.
Much research in GBS has focused on the neuromus-
cular junction (NMJ) as a potential site of anti-gangli-
oside Ab binding and injury (Halstead et al., 2005a;
Jacobs et al., 2003; O’Hanlon et al., 2001; Santafe
et al., 2005), as this structure lies outside the blood–
nerve barrier (Olsson, 1968) and thus is exposed to
blood-borne circulating factors such as autoAbs and
ganglioside-binding neurotoxins. Following the bind-
ing of anti-ganglioside Abs to ganglioside-rich plasma
membranes, one mechanism by which injury is
induced is through activation of the complement cas-
cade, which culminates in the formation of membrane
attack complex on the structures bound (Halstead
et al., 2005a). The membrane attack complex pore
allows for an uncontrolled influx of ions and water and
ultimately results in pathological changes and dys-
function of the structures targeted (Halstead et al.,
2005b; McGonigal et al., 2010). Depending on the Ab
specificity, a selective injury of the neural structures of
the NMJ, the motor nerve terminals (mNTs) or the
glial structures of the NMJ, the perisynaptic Schwann
cell (pSCs), is elicited (Halstead et al., 2005b).
Ganglioside-deficient mice (Fig. 1), generated by gly-
cosyltransferase knock-out (KO), are widely used in
experiments investigating the effects of anti-ganglio-
side Abs (Goodfellow et al., 2005; Lehmann et al.,
2007; Sheik et al., 2004). GM2-synthase (also known
as b1,4-N-acetylgalactosaminyltransferase) KO mice
(GM2sKO) mice are deficient in complex gangliosides
and express increased levels of the simple gangliosides
GM3, GD3, and GT3 (Takamiya et al., 1996). Simi-
larly, GD3-synthase (also known as a-2,8-sialyltrans-
ferase) KO mice (GD3sKO) are deficient in b- and
c-series gangliosides, whereas expressing gangliosides
of the a-series at a higher level when compared with
wildtype (WT) mice (Kawai et al., 2001; Okada et al.,
2002). Both of these strains are viable and at young
adult age do not appear to exhibit any obvious mor-
phological or behavioral phenotypes (Kawai et al.,
2001; Liu et al., 1999; Okada et al., 2002; Takamiya
et al., 1996; Zitman et al., 2008). Aged GM2sKO mice
(>9 months), however, show impaired motor behavior
with a lack of balance, coordination and strength, and
exhibit a whole body tremor (Chiavegatto et al., 2000;
Sugiura et al., 2005; Zitman et al., 2011). Age-matched
GD3sKO mice exhibit no overt neurological changes
(Zitman et al., 2011). Peripheral nerve regeneration
following axotomy is reported to be reduced in
GD3sKO mice (Okada et al., 2002). General compari-
sons of peripheral nerve regeneration in young and
aged animals have shown that even though axonal
regeneration and reinnervation of target organs are
maintained throughout life, there is a tendency for
them to be less effective in aged animals when com-
pared with their young counterparts (Verdu et al.,
1995). This age-related decrease in the regeneration
potential may reflect the fact that high age is found to
be a poor prognostic factor for GBS patients (Durand
et al., 2006; Rajabally and Uncini, 2012; van Konings-
veld et al., 2007; Walgaard et al., 2011).
This study aimed to compare the regenerative
potential of mNTs in young and aged mice following
an immune-mediated injury induced by anti-ganglio-
side Abs and complement. To be able to also provide
some information on the regenerative capacities of
mNTs in ganglioside KO strains, these investigations
were not only conducted in WT mice but also in
GM2sKO and GD3sKO mice.
MATERIALS AND METHODS
Mice
All investigations were conducted in young adult
(8–12 weeks) and aged (9–12 months) single- and
double-fluorescent homozygous GD3sKO, homozygous
GM2sKO, and WT mice, which expressed intracyto-
solic cyan fluorescent protein (CFP) in their periph-
eral motor and sensory axons and optionally also
intracytosolic green fluorescent protein (GFP) in their
Schwann cells (Feng et al., 2000; Zuo et al., 2004). To
generate these mice, single- and double-fluorescent
adult B6.Cg-Tg(Thy1-CFP6S100B-GFP) [generously
supplied by Dr. W. Thompson (Austin, TX) and now
available commercially as individual lines through
Jackson, Bar Harbor, ME] were crossed with
GD3sKO (Okada et al., 2002) and GM2sKO mice
(Takamiya et al., 1996) (imported to UK and bred
from Furukawa stock, Nagoya, Japan). Inheritance of
transgenes was confirmed by PCR and phenotyping
of ear-punches. For the latter, the subcutis of the
ears was examined for the occurrence of GFP in adi-
pocytes and CFP in axons/neurons with a compound
fluorescence microscope (Zeiss AxioImager (Zeiss,
Goettingen, Germany)).
Abbreviations
Ab antibody
CFP cyan fluorescent protein
GBS Guillain-Barre syndrome
GD3sKO GD3-synthase knock-out mouse
GFP green fluorescent protein
GM2sKO GM2-synthase knock-out mouse
KO knock-out
mNT motor nerve terminal
nAChR nicotinic acetylcholine receptor
NHS normal human serum
NMJ neuromuscular junction
pSC perisynaptic Schwann cell
SH sternohyoid muscle
WT wildtype.
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Animal groups
Following the in vivo induction and documentation
of the anti-ganglioside Ab- and complement-mediated
injury, mice were either immediately sacrificed to
assess the extent of injury (d0), or recovered and
assessed after 5 days (d5) to determine the extent of
regeneration at this time-point (n5 3 per time-point
and age/strain group). Young adult control mice,
which only received complement and were subjected
to the in vivo imaging procedures, also were assessed
at d5.
Antibodies and complement
The mouse monoclonal Abs TBG3 and EG1, both
IgG3 subclass, were generated and characterized for
ganglioside-binding profiles as described previously
(Goodfellow et al., 2005; Goodyear et al., 1999; Hal-
stead et al., 2005b) (Table I). Both these Abs were
applied topically to the muscles under investigation at
absolute values of 120 mg per mouse, diluted in sterile
Ringer’s solution (Vetivex 9, Decra, Shrewsbury, UK).
Normal human serum (NHS), which served as a
source of complement, taken from a single donor stock,
Fig. 1. Schematic overview of the synthesis and composition of gangliosides (adapted from Plomp and Wil-
lison, 2009). Mice lacking GD3-synthase (a-2,8-sialyltransferase) do not express any b- and c-series ganglio-
sides (orange box), whereas mice lacking GM2-synthase (b1,4-N-acetylgalactosaminyltransferase) do not
express any complex gangliosides (green box).
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was stored immediately after acquisition in aliquots at
270C to preserve complement activity. For in vivo
applications, NHS was diluted to a concentration of
40% in sterile Ringer’s solution and also applied topi-
cally, with each mouse receiving a total of 0.6 mL.
In vivo procedures
All procedures were conducted in accordance with
UK Home office guidelines and carried out as
described previously (Rupp et al., 2012). Briefly,
under general anesthesia the sternohyoid muscles
(SH) of the mice were first exposed to rhodamine-con-
jugated a-bungarotoxin (Molecular Probes, Eugene,
OR; 1:400 in sterile Ringer’s solution), which selec-
tively labels the nicotinic acetylcholine receptors
(nAChRs), for 10 min. After a Ringer’s wash, anti-
ganglioside Abs/Ringer’s solution (see Table I) were
applied topically for 30 min, followed by NHS (also
30 min). In vivo imaging of NMJs ensured documen-
tation of integrity and injury of the neuromuscular
structures before and after application of Ab and
complement, respectively. Originally imaged NMJs
were identified due to their location and unique
nAChR pattern.
Ex vivo procedures
For quantitative assessments of mNT injury and
regeneration at d0 or d5, respectively, fixed SH were
imaged ex vivo under coverslips with a Zeiss Axi-
oImager compound fluorescence microscope. One
hundred superficial NMJs per SH were assessed for
the presence or absence of CFP overlying the NMJ.
CFP was scored as “present” if uniformly intact (as
opposed to fragmented) CFP extending from the
efferent axon was seen overlying the NMJ, regard-
less of its morphology, intensity and extent. The per-
centage of NMJs exhibiting CFP was then
calculated for each muscle assessed (n5 2 per
mouse) and pooled for each age-group, strain, and
time-point. Chi-square or Fisher’s exact tests were
applied to determine statistical significance. The
data acquired was compared with rate of mNT
injury and recovery in young WT mice presented
recently (Rupp et al., 2012).
Imaging and image processing
In vivo images were acquired with an epifluores-
cence microscope (Leica DMI4000B), connected to a
computer via a camera (Leica DFC 350 Fx, both Leica,
Wetzlar, Germany) and combined with the appropriate
software (Leica Application Suite Version 2.5.0 RI,
Leica Microsystems CMS GmbH, Switzerland). For
contrast optimization and manual reconstruction of
stacks and composite images, a combination of ImageJ
(Version 1.38, NIH, Bethesda, MD) and Adobe Photo-
shop CS (Version 8.0, Adobe Systems Europe Limited,
Edinburgh, UK) were used.
Ex vivo images were acquired with a Zeiss AxioIm-
ager compound fluorescence microscope and semi-
automatic Zeiss Axiovision 4.7.2 imaging software
(VC Carl Zeiss Imaging Solutions GmbH, Germany).
This software was also used for the reconstruction of
stacks and optimization (background correction) of
images.
RESULTS
Anti-ganglioside Ab and complement-mediated
injury
Depending on the binding specificity of the anti-
ganglioside Ab applied, a selective injury to the
mNTs (loss of CFP overlying the NMJ) or a combined
injury to the mNTs and pSCs (loss of both CFP and
GFP overlying the NMJ) was observed (Fig. 2). In
WT mice, the application of TBG3 and complement
was associated with a selective mNT injury (WT-1),
whereas the combined application of TBG3 and EG1
lead to a combined mNT and pSC injury (WT-2). In
GM2sKO mice, the application of EG1 and comple-
ment elicited a loss of both CFP and GFP, thus induc-
ing a combined mNT and pSC injury, and in GD3sKO
mice, the application of TBG3 and complement lead
to a selective loss of CFP, thus inducing a selective
mNT injury. The application of human serum as a
source of complement (in the absence of anti-ganglio-
side Ab) and exposure of muscles to in vivo imaging
procedures did not induce any changes to the fluores-
cent proteins of the NMJ (Table I; Fig. 2).
The extent of mNT injury following an anti-gangli-
oside Ab and complement-mediated injury differed
between the various mouse strains (Fig. 3) and statis-
tically significant differences were observed when
comparing strains which had been subjected to the
same type of injury (WT-1 vs. GD3sKO: P5 0.0001;
WT-2 vs. GM2sKO: P< 0.0001). The average percent-
age of NMJs still exhibiting cytosolic CFP (i.e., intact
mNT) following induction of the injury ranged from
1.5% (GD3sKO) to 11.8% (WT-2).
Motor nerve terminal regeneration
Following 5 days of regeneration, most NMJs
assessed had recovered their CFP (Fig. 3). Whilst in
TABLE I. Antibodies applied to the different animal groups/
strains, their predominant binding specificities according to ELISA,
and the injury observed following the additional application of
complement
Group/strain Antibody
Antibody
binding
specificity
Resulting
injury
WT-1 TBG3 GD1a mNT only
WT-2 TBG31EG1 GD1a, GD3, GQ1b mNT and pSC
GD3sKO TBG3 GD1a mNT only
GM2sKO TBG31EG1 GD1a, GD3, GQ1b mNT and pSC
Control
(all strains)
None n/a None
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the two KO-strains no statistically significant differ-
ence was observed between the young animals under-
going regeneration and their controls (GM2sKO:
P5 0.19; GD3sKO: P5 0.21), a statistically signifi-
cant difference was observed between experimental
and control animals in the young adult WT mice
(P< 0.0001).
When comparing mNT regeneration in young adult
versus aged mice in the various strains (Fig. 4), no
statistically significant differences could be observed
in the WT mice (regardless of the injury type) and
the GM2sKO mice. Only the aged GD3sKO mice
showed significantly impaired mNT regeneration
when compared with their younger counterparts
(P5 0.0009).
Comparison of mNT regeneration in the young age-
groups with one another revealed no statistically sig-
nificant difference between both groups experiencing
a mNT injury only (WT-1 vs. GD3sKO; P5 0.45) and
both groups experiencing a combined mNT and pSC-
injury (WT-2 vs. GM2sKO; P5 0.12). The same was
observed for the aged experimental groups (WT-1 vs.
GD3sKO, P5 0.20; WT-2 vs. GM2sKO, P5 0.53).
DISCUSSION
WT mice appear predominantly to express complex
gangliosides (including GD1a) in their mNTs and
simple gangliosides (including GD3) in their pSCs
(Halstead et al., 2005b; Rupp et al., 2012). Therefore,
Fig. 2. Examples for injury and regeneration of the presynaptic
structures in the different mouse strains. A: Isolated mNT injury in
an aged GD3sKO mouse. B: Combined mNT and pSC injury in an
aged GM2sKO mouse. C: Young control GD3sKO mouse. Note the
selective loss of CFP overlying the NMJ (depicted by the nAChRs)
in (A), whereas in (B) both GFP and CFP are lost following induc-
tion of the injury. After 5 days of the regeneration, both GFP and
CFP are recovered, with an increased number of GFP-positive cell
bodies overlying the NMJ in (B). No changes to the fluorescent pro-
teins are noted in the control mouse (C), which only received com-
plement, was subjected the in vivo imaging procedures and also
was reimaged after a 5-day interval. Scale bars: 20 lm; pre- and
post-injury images were acquired in vivo.
Fig. 3. Extent of mNT injury and regeneration (assessed by CFP
overlying the NMJ) following application of anti-ganglioside Abs
and complement in young adult WT, GD3sKO, and GM2sKO mice.
Due to ganglioside expression and specificity of the anti-ganglioside
Abs applied, WT-1 and GD3sKO mice experienced a selective mNT
injury, whereas WT-2 and GM2sKO mice experienced a combined
mNT and pSC injury. Following 5 days of regeneration, most NMJs
under examination exhibited CFP and the values obtained in the
experimental groups tallied very closely with their control counter-
parts. In the two KO strains, no statistically significant differences
were observed between experimental and control tissue (GD3sKO:
P50.21, Fisher’s exact test, n53; GM2sKO: P50.19, Fisher’s
exact test, n53), whereas, in the two WT groups, statistically sig-
nificant differences were observed between experimental and con-
trol tissue (P< 0.0001, Chi-square test, n53). Data for each group
is presented as mean and standard error of the mean.
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the application of an anti-GD1a Ab, in conjunction
with a source of complement, leads to a selective
injury of the mNTs, whereas the joint application of
Abs binding both GD1a and GD3 in conjunction with
a source of complement is associated with a combined
mNT and pSC injury. GM2sKO mice express no com-
plex gangliosides, inferring that in these mice the
truncated ganglioside biosynthesis in the motor neu-
rone cell body limits the mNT repertoire to simple
gangliosides. The application of an anti-GD3 Ab,
therefore, leads to an injury of both mNTs and pSCs.
In GD3sKO mice, the mNTs are still able to express
0- and a-series gangliosides; thus, the application of
an anti-GD1a Ab, in conjunction with a source of
complement, results in a selective mNT injury.
When comparing the extent of mNT regeneration
between young adult and aged mice of the different
strains and injury types, only very subtle differences
were observed. This may be due to the fact that the
regenerating mNTs only need to extend a very short
distance in this specific experimental paradigm. Simi-
lar investigations involving the application of black
widow spider venom (a-latrotoxin) which induces a
mNT injury very closely resembling anti-ganglioside
Ab- and complement-mediated injury in its mecha-
nism, morphology, and time-frame of regeneration,
also indicate only very subtle differences in the rate
of mNT regeneration when comparing 5–7- and 27–
30-month-old mice (Robbins et al., 1990). The slightly
lower rate of mNT regeneration found in aged WT
and GD3sKO mice when compared with their
younger counterparts may reflect the observation
that mNT sprouting is decreased in aged animals
(when compared with young animals), and that the
average rate of regeneration also slows with increas-
ing age (Hopkins et al., 1986; Pestronk et al., 1980).
This also might serve as a potential explanation for
the poorer clinical prognosis of aged GBS-patients
when compared with younger GBS-patients (Durand
et al., 2006; Rajabally and Uncini, 2012; van
Koningsveld et al., 2002, 2007; Walgaard et al., 2011).
Previous investigations in WT mice have shown
that the acute anti-ganglioside Ab-mediated injury
remains very localized to the area of the NMJ, whilst
over the following 24 h injury extends proximally up
to a maximum of 200 mm (Rupp et al., 2012). Consid-
ering a one-day time-point was not investigated in
this study, it is not known whether this proximal
extension varies between strains.
When assessing the extent of acute mNT injury (as
assessed by the percentage of NMJs exhibiting the
normal appearance of unfragmented CFP overlapping
the bungarotoxin signal), and bearing the two differ-
ent types of injuries in mind (mNT or combined mNT
and pSC injury), statistically significant differences
were observed between the different strains. The
ensuing extent of mNT regeneration was comparable
between the different strains experiencing the same
type of injury. At the same time, previous and cur-
rent investigations conducted in young adult and
aged WT mice have indicated that the rate of mNT
regeneration in this experimental setting is inde-
pendent of healthy pSCs overlying the NMJ (Rupp
et al., 2012). Considering pSCs have been shown to
major play a role in supporting reinnervation of the
NMJ following traumatic denervation (Son and
Thompson, 1995; Son et al., 1996) this finding is
rather unexpected. To account for this, we previously
have suggested that either the anti-ganglioside Ab-
and complement-mediated injury to the pSCs is sub-
lethal or the complement-killed pSCs are very rapidly
replaced by immature precursors. In both these situa-
tions, a pSC population may be able to support mNT
regeneration (Rupp et al., 2012). Similar to observa-
tions made following denervation and reinnervation
of traumatically denervated NMJs (Love and Thomp-
son, 1998; Reynolds and Woolf, 1992), the (immature)
pSCs in the current experimental setting also extend
processes beyond the NMJ-boundaries and increased
numbers of GFP-positive structures overlying the
reinnervated NMJs are found on day 5 (Rupp et al.,
2012; see also Fig. 2B).
Considering the relative comparability of the extent
of mNT regeneration in the different strains (WT-1
vs. GD3sKO and WT-2 vs. GM2sKO), similar findings
were observed in a study investigating the role of
Fig. 4. Extent of mNT regeneration (assessed by CFP overlying
the NMJ) following 5 days of regeneration in young and aged WT,
GD3sKO, and GM2sKO mice. Due to ganglioside expression and
specificity of the anti-ganglioside Abs applied, WT-1 and GD3sKO
mice experienced a selective mNT injury, whereas WT-2 and
GM2sKO mice experienced a combined mNT and pSC injury. Com-
paring the young and aged mice undergoing mNT regeneration, a
statistically significant difference was only observed for the
GD3sKO mice (P50.0009; Fisher’s exact test, n53). Statistically,
no significant differences were observed between the young or aged
experimental groups experiencing mNT injury only (WT-1 vs.
GD3sKO, young: P5 0.45, aged: P50.20; Fisher’s exact test, each
n53) and groups experiencing a combined mNT and pSC injury
(WT-2 vs. GM2sKO, young: P5 0.12, aged: P5 0.53; Fisher’s exact
test, each n5 3). Data for each group is presented as mean and
standard error of the mean.
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gangliosides and the effect of anti-ganglioside Abs in
peripheral nerve regeneration. Here, the amount of
regenerating fibres at the sciatic level (i.e., close to the
site of injury) was comparable between WT, GM2sKO,
and GD3sKO mice (Lehmann et al., 2007). Interest-
ingly, at the tibial level (a point further distal), fewer
regenerating myelinated fibres were observed in
GM2sKO mice when compared with the other two
strains, indicating that complex gangliosides might be
necessary for regeneration over longer distances and
that subtle differences in regeneration cannot be
detected over short distances, such as those covered by
the regenerating mNTs in this study. Alternatively,
the regeneration of distal nerve and mNT-components
may rely less heavily on the presence of complex gan-
gliosides when compared with the mechanisms of long
distance axonal regeneration, or can be compensated
for by the overexpression of simple gangliosides (Taka-
miya et al., 1996). Assessment of intermediate time-
points (e.g., 2 or 3 days) after induction of the injury
might shed further light on this.
We have previously shown that the presence of CFP
following 5 days of regeneration coincides with a resto-
ration of the normal morphology of the NMJ at the ul-
trastructural level; however, it remains possible that
the crude evaluation of the presence/absence of CFP
used as a global indicator for mNT restoration in this
study might be inadequate to detect subtle differences
between the strains and between young adult and
aged mice. Considering, however, that young adult WT
mice require 5 days to regenerate their mNTs following
a single anti-ganglioside Ab-mediated injury (Rupp
et al., 2012) and taking the apparent roles of age and
complex gangliosides in axonal regeneration described
above into account, one would not expect aged or KO
mice to regenerate faster than young adult WT mice.
Also containment of the CFP within the mNTs indi-
cates that at least the gross structure including the
axolemmal integrity has been re-established. Alterna-
tively, exacerbation of the insult by repeated applica-
tions of anti-ganglioside Abs and complement, or the
possible proximal extension of the lesion following a
breakdown of the blood–nerve barrier, might be able to
illuminate any differences in the regenerative capaci-
ties of young adult versus aged mice or WT versus gan-
glioside-deficient mice, whereas at the same time
being able to mimic the clinical situation in GBS-
patients more accurately.
Out of all groups, the aged GD3sKO mice per-
formed least well with respect to mNT regeneration
capacity, consistent with previous reports that these
mice have impaired peripheral nerve regeneration
(Okada et al., 2002). Following peripheral nerve
resection, the application of b-series ganglioside
GT1b in (WT) rats appears to be more effective in
preventing neuronal death and promoting nerve
regeneration when compared with other gangliosides
(Itoh et al., 2001). Also, the application of GT1b in
mice lacking complex gangliosides also markedly
increases the number of surviving neurons and pro-
motes nerve regeneration (Kittaka et al., 2008). The
overexpression of a-series gangliosides such as GM1,
which has been shown to be neurotrophic (Doherty
et al., 1985; Duchemin et al., 2002), may be able to
compensate for the lack of b- and c-series ganglio-
sides in young GD3sKO mice.
In summary, this study has shown that the rate of
mNT regeneration—following an anti-ganglioside Ab-
and complement-mediated injury and independent of
the presence of healthy pSCs overlying the NMJ—
does not differ majorly between young adult or aged
mice. Aged mice exhibited only a slight tendency for
slower or less complete mNT regeneration. At the
same time, mice deficient in b- and c-series ganglio-
sides and mice deficient in all complex gangliosides
regenerate equally well as WT mice in the current
experimental setting. These findings suggest that ei-
ther the very discrete and localized events mediating
mNT regeneration do not rely heavily on complex
gangliosides, or b- and c-series gangliosides or that
the lack of either of these might successfully be com-
pensated for by overexpression of the remaining gan-
gliosides in these mice.
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